Efficacy in the Reduction of Hypersensitivity During Home Whitening With 16% Carbamide Peroxide Applied on Alternate Days

Sponsor
Universidad Rey Juan Carlos (Other)
Overall Status
Recruiting
CT.gov ID
NCT06035588
Collaborator
(none)
110
1
2
9.4
11.7

Study Details

Study Description

Brief Summary

The concentration of 16% carbamide peroxide is the highest concentration that European regulations allow for use in home whitening (Council directive 2011/84/EU). This concentration allows for faster results, but instead patients may suffer more frequently from dental sensitivity. The most commonly described side effect of all whitening procedures is the appearance of dentin hypersensitivity, hence the efforts to counteract or overcome this adverse effect.

The objective of the study is to clinically evaluate the difference in dental hypersensitivity produced by home dental whitening treatment using 16% carbamide peroxide in a tray for two hours daily applied daily or every other day for three weeks.

Condition or Disease Intervention/Treatment Phase
  • Other: Daily whitening
  • Other: Alternate whitening
N/A

Detailed Description

Volunteers will be instructed to use the whitening gel once a day for 2 hours, completing a total of 3 weeks of whitening procedure. Depending on the randomization, the bleaching procedure will be performed every other day or daily. In the upper arch, the teeth to be whitened will be from 15 to 25. The evaluations of efficacy, dental sensitivity and satisfaction will be carried out in the upper and lower arch. The color will be recorded before, weekly for 1 month, 6 months and 12 months after finishing the treatment. Shade assessment using the subjective method will be recorded with the Vita Classical color scale (Vita Zahnfabrik, Bad Säckingen, Germany), it will also be determined with the Vita 3D-MASTER scale (Vita Zahnfabrik, Bad Säckingen, Germany). For objective evaluation, the Vita Easyshade spectrophotometer (Vita Zahnfabrik, Bad Säckingen, Germany) will be used, according to the CIELab* system.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Each volunteer will be given 3 syringes of 16% carbamide peroxide bleaching gel to use on the splint. Volunteers will be instructed to use the whitening gel once a day for 2 hours, completing a total of 3 weeks of whitening procedure. Depending on the randomization, the whitening procedure will be performed on alternate days or daily. In the upper arch, the teeth to be whitened will be from 15 to 25 and in the lower one from 35 to 45.Each volunteer will be given 3 syringes of 16% carbamide peroxide bleaching gel to use on the splint. Volunteers will be instructed to use the whitening gel once a day for 2 hours, completing a total of 3 weeks of whitening procedure. Depending on the randomization, the whitening procedure will be performed on alternate days or daily. In the upper arch, the teeth to be whitened will be from 15 to 25 and in the lower one from 35 to 45.
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
The present study presents blinding of both the evaluator and the person who will carry out the statistical analysis, and therefore double-blind. The evaluators are considered blind in this study because they do not know the randomization of the patients, being a blind study. The operator and patients know the groups in which they are assigned, due to the delivery and placement of the splints. A block randomization of the treatment applied to the patients will be carried out, to ensure that the sample size is similar in both groups. The operator will open an envelope for the group's allocation. The assignment of the groups will be carried out using opaque, sealed and sequentially numbered envelopes. The operator will open the envelope when the splints are delivered, and will give the pertinent explanations to the patient. Data will be collected from each patient that may influence treatment results such as age, sex, initial color, systemic pathologies and pharmacological treatments.
Primary Purpose:
Treatment
Official Title:
Efficacy in the Reduction of Hypersensitivity During Home Whitening With 16% Carbamide Peroxide Applied on Alternate Days: a Randomized Clinical Trial
Anticipated Study Start Date :
Sep 6, 2023
Anticipated Primary Completion Date :
Oct 27, 2023
Anticipated Study Completion Date :
Jun 17, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Daily whitening

Volunteers should whiten daily with a whitening tray from 15 to 25 and 35 to 45 for 2 hours. This procedure will last 3 weeks.

Other: Daily whitening
Daily application of a 16% carbamide peroxide bleaching gel in volunteers without sensitivity.

Experimental: Alternate whitening

Volunteers will bleach for 3 weeks with 16% carbamide peroxide, alternating one rest day for each placement day. They will wear a whitening tray from 15 to 25 and from 35 to 45 for 2 hours.

Other: Alternate whitening
Volunteers will apply the whitening gel at 16% carbamide peroxide, alternating a rest day with an application day. Patients should not be sensitive before starting the study.

Outcome Measures

Primary Outcome Measures

  1. Dental Sensitivity [3 weeks]

    The objective of the study is to clinically evaluate the appearance of dental sensitivity produced by the home dental whitening treatment using 16% carbamide peroxide applied in a tray for two hours daily each day or using it on alternate days for three weeks.

Secondary Outcome Measures

  1. whitening efficacy [1 month]

    To assess whether the efficacy of the 16% carbamide peroxide whitening treatment described above applied every other day is the same as when used every day or is there a difference in whitening efficacy. This will be determined instrumentally with the Vita EasyShade V® spectrophotometer, based on the CIEL*a*b* system, according to the CIELAB, CIEDE2000 system and the whiteness index.

Other Outcome Measures

  1. Gingival irritation [3 weeks]

    To compare the existence of gingival irritation using the Visual Analog Scale after the application of bleaching every two days with 16% carbamide peroxide, compared to the daily application.

  2. Patient's oral quality of life [1 month]

    To assess the impact on the patient's oral quality of life (OHIP-14) in terms of treatment results using a questionnaire, after applying home whitening with 16% carbamide peroxide every other day, instead of applying it daily.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients older than 18 years.

  • Patients with vital teeth without restorations, single crowns, implants and/or bridges at the level of the anterior teeth.

  • Absence of cavities in the teeth to be whitened.

  • Patients with satisfactory oral hygiene and periodontally healthy, who are not undergoing periodontal maintenance and who do not use chlorhexidine mouthwashes. Patients with recessions without presenting sensitivity will be included.

  • Absence of sensitivity, measured with the application of air with the dental team's syringe.

  • Patients whose canines have at least an A2-A3 shade (VITA Classic® Guide).

Exclusion Criteria:
  • Patients who have previously undergone whitening (less than 5 years).

  • Patients undergoing orthodontic treatment.

  • Patients with white spots or alterations in the development of enamel or with stains.

  • Patients with a history of trauma to anterior teeth.

  • Patients who require internal whitening.

  • Smokers.

  • Pregnant or lactating.

  • Patients with allergies to any whitening component.

  • Patients presenting alterations of the oral mucosa (desquamative gingivitis, oral lichen planus, leukoplakia, etc.).

  • Patients with medical conditions considered by the researchers that may compromise the study or the individual safety of the patient.

  • Patients with poor oral hygiene.

  • Patients with previous hypersensitivity.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Isabel Giraldez de Luis Alcorcón Madrid Spain 28922

Sponsors and Collaborators

  • Universidad Rey Juan Carlos

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Isabel Giráldez de Luis, Lecturer of Department for Conservative Dentistry at Rey Juan Carlos University, Universidad Rey Juan Carlos
ClinicalTrials.gov Identifier:
NCT06035588
Other Study ID Numbers:
  • URJC University
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Isabel Giráldez de Luis, Lecturer of Department for Conservative Dentistry at Rey Juan Carlos University, Universidad Rey Juan Carlos
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2023